The US' National Institutes of Health (NIH) has halted a clinical trial evaluating the safety and effectiveness of Covid-19 convalescent plasma in treating emergency department patients who develop mild to moderate symptoms.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3sJrziL
via gqrds
US halts trial of Covid-19 convalescent plasma The US' National Institutes of Health (NIH) has halted a clinical trial evaluating the safety and effectiveness of Covid-19 convalescent plasma in treating emergency department patients who develop mild to moderate symptoms. https://ift.tt/eA8V8J
Virus variant in Brazil infected many who had already recovered from Covid B.1.1.7, first identified in Britain, has demonstrated the power to spread far and fast. In South Africa, a mutant called B.1.351 can dodge human antibodies, blunting the effectiveness of some vaccines. https://ift.tt/eA8V8J
Vaccine passports, Covid’s next political flashpoint The idea is to allow families to reunite, economies to restart and hundreds of millions of people who have received a shot to return to a degree of normalcy, all without spreading the virus. https://ift.tt/eA8V8J